Chemotherapie bei Leukämie in Israel — erhalten Sie 3 personalisierte Klinikempfehlungen

Israel leads in leukemia treatment with board-certified hematologists who pioneer molecular diagnostics and gene therapy. These specialists practice at JCI-accredited centers like Sourasky and Hadassah. They offer advanced chemotherapy and stem cell transplants. Many received elite training at Memorial Sloan-Kettering and Stanford University.

• International training: Professors like Dina Ben-Yehuda trained at Memorial Sloan-Kettering Cancer Center.
• Pediatric expertise: Dr. Ronit El Hasid has performed 300+ bone marrow and cord blood transplants.
• CLL specialization: Dr. Herishanu Yair received 10+ awards for chronic lymphocytic leukemia research.
• Stem cell leadership: Dr. Arnon Nagler founded Israel's first public cord blood bank.

Bookimed Expert Insight: Coordination data shows that top Israeli hematologists often hold dual roles as department heads and active researchers. For example, Dr. Ofer Merimsky and Dr. Ronit El Hasid at Sourasky Medical Center provide direct access to protocols usually found in clinical trials. Patients can also book video consultations with these experts, with fees ranging from $950 to $1050.

Patient Consensus: Patients note that major Israeli medical centers provide clear treatment protocols and fast appointment scheduling. They appreciate that senior doctors like Dr. Michael Shapira are fluent in English. International families often emphasize the professional organization when coordinating complex transplants for children.

Top pediatric leukemia specialists in Israel include board-certified experts at JCI-accredited centers like Sourasky and Assuta. These leaders specialize in complex bone marrow transplants and advanced chemotherapy. Many hold fellowships from premier US institutes like Memorial Sloan-Kettering and City of Hope Hospital.

• Dr. Ronit El Hasid: Directs pediatric oncohematology at Sourasky and has performed 300+ successful transplantations.
• Dr. Dror Levin: Senior deputy director specialized in complex childhood blood disorders and soft tissue oncology.
• Dr. Fredi Aviv: Board-certified specialist with 30+ years of experience focused exclusively on leukemia cases.
• Professor Dvora Blumental: Expert in treating nervous system complications from leukemia with Sloan-Kettering training.

Bookimed Expert Insight: Data shows a high concentration of specialists with international backgrounds in Tel Aviv. For example, Dr. Ofer Merimsky and Dr. Ronit El Hasid bring specialized fellowship experience from Paris and Los Angeles. This exposure allows them to implement diverse chemotherapy protocols often unavailable in standard regional hospitals.

Patient Consensus: Parents note that children often reach remission within weeks using tailored protocols after previous treatments failed. They frequently mention the relief of findng English-speaking staff and supportive family lodging during long stays. Many families also appreciate starting with video consultations to avoid travel delays.

Israel leads in CAR T-cell therapy through specialized hematologists and early adoption of cellular protocols. Top experts like Dr. Herishanu Yair and Prof. Arnon Nagler deliver these advanced immunotherapies at JCI-accredited centers. These specialists focus on refractory leukemia using FDA-approved and in-house developed cell products.

• Dr. Herishanu Yair: Expert in CAR T-cell therapy at Sourasky Medical Center with 10+ research awards.
• Prof. Arnon Nagler: 35+ years experience and pioneer of bone marrow transplantation at Sheba Medical Center.
• Prof. Dina Ben-yehuda: Leading hematology expert at Hadassah focusing on gene therapy and molecular diagnostics.
• Dr. Ronit El Hasid: Directed over 300 pediatric transplantations and specializes in childhood leukemia therapies.

Bookimed Expert Insight: Data shows that choosing specialists at larger academic centers like Sourasky or Hadassah provides faster access to varied cell lines. For instance, Dr. Ofer Merimsky offers consultations for $950, which often includes a comprehensive review of eligibility for advanced trials. These institutions frequently run parallel tracks for both commercial and experimental CAR-T protocols.

Patient Consensus: Patients note that pediatric programs often provide faster access to CAR-T for children and teenagers. Families emphasize the importance of having bridging chemotherapy ready to remain eligible for the procedure. Many were surprised by the intensive monitoring required for neurotoxicity but felt reassured by the rapid medical response.

Israeli hematologists maintain standards equivalent to US doctors through rigorous medical training and international fellowships. Many specialists hold certifications from the American Society of Hematology. They often train at elite institutions like Memorial Sloan-Kettering and Stanford University to master advanced leukemia protocols.

• International training: Top doctors completed fellowships at Stanford, Memorial Sloan-Kettering, and New York Medical College.
• Academic leadership: Many serve as professors at Hebrew University and lead international cancer research committees.
• Extensive experience: Specialists like Dr. Ivetta Danylesko from Sheba have performed over 3,000 hematology procedures.
• Research contributions: Leading experts have published over 50 scientific papers on innovative leukemia and transplant therapies.

Bookimed Expert Insight: Data shows that Israeli hematology leadership is defined by long-term clinical continuity at top centers. For example, Dr. Arnon Nagler at Sheba Medical Center has 35+ years of experience and pioneered the nation's first public cord blood bank. This deep local expertise, combined with training from US institutions like Stanford, ensures patients receive globally recognized care in Tel Aviv and Jerusalem.

Patient Consensus: Patients note that Israeli hospitals often provide faster diagnostic turnaround times for urgent leukemia cases compared to the US. They also feel reassured that the chemotherapy protocols follow the exact same international NCCN and ESMO guidelines used in American clinics.

Most senior hematologists in Israel speak fluent English because they complete fellowships at top American and European hospitals. Many leading specialists such as Professor Michael Shapira at Sourasky Medical Center (Ichilov) specifically provide English-language care for international patients seeking complex leukemia chemotherapy.

• International training: Top doctors hold fellowships from Memorial Sloan-Kettering and Stanford University.
• Academic expertise: Leading hematologists regularly publish research in English-language international medical journals.
• Staff communication: Major hospitals maintain dedicated international departments with fluent English-speaking patient coordinators.
• Consultation accessibility: Specialists like Dr. Dvora Blumental offer English-language video consultations for $1050.

Bookimed Expert Insight: Data shows that senior department heads at clinics like Sourasky or Sheba almost always have extensive North American training. For example, Dr. Ron Ram completed his fellowship at New York Medical College. This pattern ensures that patients receive explanations in familiar medical English, which is vital for understanding complex protocols like stem cell transplants.

Patient Consensus: Patients note that while some administrative staff might only speak Hebrew, the doctors and senior specialists are highly fluent in English. They emphasize the importance of requesting an international coordinator to ensure smooth communication during long-term chemotherapy treatments.

Yes, you can secure an online consultation with top Israeli leukemia specialists through Bookimed. Expert hematologists provide remote second opinions and treatment plan reviews via video calls. Most leading doctors hold American or European board certifications and have trained at centers like Memorial Sloan-Kettering.

• Expert credentials: Surgeons like Dr. Ron Ram are board-certified in Hematology and Medical Oncology.
• Specialized focus: Dr. Ronit El Hasid leads pediatric units, performing 300+ successful transplantations.
• Consultation accessibility: Many senior specialists offer remote evaluations for patients with complex blood cancers.
• Academic leadership: Doctors like Dr. Dina Ben-yehuda serve as deans of major medical schools.

Bookimed Expert Insight: Analysis of specialist profiles reveals that top Israeli hematologists offer unique international expertise. For instance, Dr. Ofer Merimsky at Sourasky Medical Center provides consultations for $950, reflecting deep specialization in rare sarcoma-related leukemias. Patients can also access specialists with 30+ years of experience, such as Dr. Fredi Aviv, who handles both adult and pediatric cases at JCI-accredited facilities.

Patient Consensus: Patients value the professionalism and ease of organizing video calls with renowned professors. Many note that having a clear connection to a specialist helps clarify their diagnosis before travel. They often feel more confident after discussing advanced targeted therapies with doctors who speak fluent English.